MedPath

Effect of Different Form of Upper Limb Muscles Training on Dyspnea in COPD

Not Applicable
Completed
Conditions
COPD
Interventions
Other: Strength training
Other: Endurance training
Registration Number
NCT03611036
Lead Sponsor
University Hospital, Brest
Brief Summary

Evaluate the effect of upper limbs strength training versus the effect of upper limbs endurance training, on dyspnea, in patients with COPD during a pulmonary rehabilitation program.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
280
Inclusion Criteria
  • Patient with stage 2 to 4 (A to D) COPD admitted to a pulmonary rehabilitation program (4 weeks)
  • Patient aged 18 or over
  • Patient able to consent and having signed a consent form
Exclusion Criteria
  • Patient with pain, osteoarthritis or shoulder surgery
  • Patient with a history of Pneumonectomy, lobectomy less than 6 months old
  • Refusal of participation
  • Patient with an inability to complete a pulmonary rehabilitation program in totality
  • Pregnant or breast-feeding women
  • Patient under tutorship or curatorship

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
StrengthStrength trainingPatients will follow the pulmonary rehabilitation program associated with upper limbs strength training for a duration of 4 weeks
EnduranceEndurance trainingPatients will follow the pulmonary rehabilitation program associated with upper limbs endurance training for a duration of 4 weeks
Primary Outcome Measures
NameTimeMethod
Compare the effect of upper limbs strength training versus the effect of upper limb endurance training on dyspnea in patients with COPD during a pulmonary rehabilitation program.Change from inclusion at 4 week

Measurement of dyspnea using the London Chest Daily Activity Living (LCADL) questionnaire.

This 15-item, self-administered questionnaire allows an evaluation of dyspnea in patients with COPD during daily activities divided into four components: self-care, domestic, physical, and leisure. Patients could score from 0: "I would not do anyway" to 5: "I need someone else to do this". LCADL score is calculated by aggregating the points assigned to each question, with a higher score representing maximal disability.

Secondary Outcome Measures
NameTimeMethod
Compare the evolution of upper limb strength between the 2 groups.At inclusion and week 4

Measurement of the strength of deltoids, biceps and brachial triceps, with hand held dynamometer

Compare dyspnea in daily life between the 2 groupsAt inclusion and week 4

Measurement of dyspnea using Dyspnea-12 questionnaire. This 12-item self-administered questionnaire measures dyspnea severity in both its physical and affective components, independently from activity limitation. Patients score ranges from "none" (corresponding to score 0) to "severe" (score 3). Dyspnea-12 score is calculated by aggregating the points assigned to each question; the higher the score, the greater the severity.

Measuring upper limb enduranceAt inclusion and week 4

with the 6-minute Peg Board and Ring Test (6PBRT)

Compare upper limbs muscle fatigue at the end of a functional test using the upper limbsAt inclusion and week 4

Measurement of upper limbs muscle fatigue with Borg scale at the end of 6PBRT. The measure is a rating on a scale from 0 to 10 attached to different words of appreciation: "very light, difficult, painful ..." effort.

Compare dyspnea at the end of a functional test using the upper limbsAt inclusion and week 4

Measurement of dyspnea with Borg scale at the end of 6PBRT. The measure is a rating on a scale from 0 to 10 attached to different words of appreciation: "very light, difficult, painful ..." effort.

Trial Locations

Locations (2)

CHRU de Brest

🇫🇷

Brest, France

CH Pays de Morlaix

🇫🇷

Morlaix, France

© Copyright 2025. All Rights Reserved by MedPath